About

We are economists who challenge conventional wisdom and advance ideas to better serve society.

Research

We develop research that challenges economic orthodoxy and serves society.

Perspectives

Articles and videos on pressing economic and social issues from members of the INET community.

Education

We develop resources for students and educators interested in exploring new economic thinking.

Webinars

To foster new economic thinking, we host convenings that gather together a diverse community of thinkers from different fields, countries, and schools of thought.

For Media

INET brings together more than 450 Nobel laureates, scholars, policy minds and business leaders who are helping to shape economic thinking worldwide.

Topics

Browse all INET content organized by topic

Matt Hopkins

  • Senior Researcher, The Academic-Industry Research Network
Involvement

By this expert

The $5.3 Trillion Question Behind America’s COVID-19 Failure

Article By William Lazonick and Matt Hopkins | Jul 24, 2020

That’s the amount of buybacks U.S. corporations funneled to shareholders during the past decade—rather than invest in technologies for the common good. This article is being published jointly by INET and The American Prospect

How “Maximizing Shareholder Value” Minimized the Strategic National Stockpile: The $5.3 Trillion Question for Pandemic Preparedness Raised by the Ventilator Fiasco

Paper Working Paper | By William Lazonick and Matt Hopkins | Jul 2020

The success of projects for pandemic preparedness and response depends on the strength of government-business collaborations.

4 Ways to Eradicate the Corporate Disease That is Worsening the Covid-19 Pandemic

Article By William Lazonick, Matt Hopkins, Ken Jacobson, Lenore Palladino, Mustafa Erdem Sakinç, and Öner Tulum | Mar 23, 2020

It’s time for business executives, employees, and taxpayers to come together to help get us out of the pandemic and create conditions for a sustainable and equitable future

Financialization of the U.S. Pharmaceutical Industry

Article By William Lazonick, Öner Tulum, Matt Hopkins, Mustafa Erdem Sakinç, and Ken Jacobson | Dec 2, 2019

Pharmaceutical drugs are often a matter of life or death. It should be a prime objective of government policy to rid the industry of financialization.